Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07807956) titled 'A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous ABBV-253 Moves Through the Body in Adult Participants With Advanced Solid Tumors' on Sept. 1.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: AbbVie
Condition:
Advanced Solid Tumors
Non-Small Cell Lung Cancer
Colorectal Cancer
Pancreatic Ductal Adenocarcinoma
Gastric Cancer
Gastroesophageal Junction Adenocarcinoma
Biliary Tract Cancer
Head and Neck Squamous Cell Carcinoma
Ovarian Cancer
Intervention...